Continuous adductor canal block after TKA may improve recovery

NEW ORLEANS — Results presented here showed continuous adductor canal block after total knee arthroplasty may improve recovery and pain scores and decrease opioid use in the first 72 hours after surgery.
“[These results] will help inform more standardized multimodal pathways for pain control for patients undergoing joint replacement,” Jesse I. Wolfstadt, MD, Granovsky Gluskin chair in orthopedic reconstruction at Mount Sinai Hospital and the University of Toronto, told Healio about results presented at the American Academy of Orthopaedic Surgeons Annual Meeting. “It

Custom osseointegration implants may have reliable outcomes

NEW ORLEANS — Results showed custom electron beam melting 3D-printed implants may reliably osseointegrate without loosening and have similar short-term functional outcomes vs. other press-fit osseointegration options.
“Within the last 5 to 10 years there has been a lot more industry that has been capable of quickly turning around custom titanium implants with a textured surface that can achieve osseointegration and be made whatever shape we need it to be made,” Taylor J. Reif, MD, an orthopedic surgeon at the Osseointegration Limb Replacement Center at Hospital for Special Surgery, told Healio

Luminopia shows promise in intermittent exotropia

Luminopia significantly improved control of intermittent exotropia in a pilot study of younger children, according to a press release.
“While this is a small pilot study, the combination of improved motor control and a signal in sensory fusion suggests that dichoptic therapy warrants further investigation in larger controlled trials,” Shelley Hancock, senior director of medical affairs at Luminopia, told Healio.
The study included 10 children between the ages of 4 and 7 years old who were treated with Luminopia for 3 months and checked again after a 3-month washout period. They were

Binkhorst Lecture: Practices should implement AI now

WASHINGTON — When considering AI in ophthalmic practice, the question is no longer whether to implement it but rather how quickly a practice can adopt it into its workflow, according to a presenter.
At the American Society of Cataract and Refractive Surgery meeting, Kerry D. Solomon, MD, delivered the 2026 Cornelius D. Binkhorst, MD, Lecture, overviewing four areas in which practices can integrate AI.
The first is the use of ambient scribes.
“It’s efficient, it’s cost-effective, and it’s a nice way to have scribes for all our providers,” Solomon said. “We estimate that it will save 45 minutes

Capacity to deliver orthopedic care depends on price transparency

For the past 30 years, my leadership roles in private practice, employed physician groups, ASCs and hospital administration have provided valuable insights into patient questions about how charges vary by insurance and cash-pay.
The confusion occurs because the listed price for a surgical procedure, such as total joint replacement, may differ by more than 50% depending on where the procedure is performed and the payment method. In addition, the transparency bills and rules passed by Congress in recent years, including the Hospital Price Transparency Rule and the No Surprises Act, have been

Novel study shows impact of staph prevention measures in NICU

CHICAGO — Using genome sequencing, researchers found that the infection-prevention practices of using an antibiotic ointment and antiseptic wash in the NICU greatly reduced the spread of staph bacteria.
“Our findings are the first to use whole genome sequencing to show that Staphylococcus aureus screening and targeted decolonization reduce transmission among infants in a NICU,” researcher Sarah Hochman, MD, section chief of infectious diseases at Tisch Hospital and assistant professor of medicine at NYU Grossman School of Medicine, told Healio. “We show the direct

Handheld keratoconus screening device shows promise

WASHINGTON— A handheld screening device for keratoconus showed promise for corneal image capture and may offer clinicians an ergonomic tool to identify patients at risk for the condition, according to a presenter.
“We know that a significant number of patients with keratoconus go undiagnosed and untreated. This is a major problem in this country and even more so around the world,” Michael B. Raizman, MD, said at the American Society of Cataract and Refractive Surgery meeting. “There are reasons for this: Optometrists and ophthalmologists often lack access to topography and tomography devices.

Alopecia areata risk in atopic dermatitis falls with dupilumab

After receiving dupilumab vs. topical corticosteroid or prednisone for up to 24 months, the risk for alopecia areata development among patients with atopic dermatitis fell, according to study results.
These data were published in The Journal of Allergy and Clinical Immunology: In Practice.
“The results of this study further support that type 2 inflammation may play a pathogenic role in alopecia areata in at least some patients,” Benjamin Ungar, MD, assistant professor of dermatology and director of the Alopecia Center of Excellence and the Rosacea & Seborrheic Dermatitis Clinic at the Icahn

TMS for adolescent depression shows promise with limitations

Adolescent major depressive disorder represents a personal and public health challenge.
Conventional drug treatments don’t work very well, leading to only small and unimportant differences and concerning side effects, including increased suicidal ideation. These antidepressant medicines now have a black box warning from the FDA, which is the most severe warning the agency can issue.
Transcranial magnetic stimulation, a noninvasive neuromodulation technique, has emerged as a first-line alternative for depression in adolescent populations. Recent evidence warrants careful examination of both its

FDA clears Onclarity kit for at-home cervical cancer screening

The FDA has cleared an HPV self-collection kit and approved a related HPV assay for at-home use, enabling patients to obtain their own sample for cervical cancer screening.
The Onclarity HPV Self-Collection Kit (Waters Corp.) is tested with the BD Onclarity HPV Assay (Waters Corp.), which now supports specimens collected both in clinic and at home. The assay detects all high-risk, carcinogenic genotypes and is the only FDA-approved HPV assay to identify “six individually and three groups of pooled results,” according to a manufacturer press release.
The at-home, self-collection kit could help